Sign in

CIK 0001735438

  • Non-accelerated filer
  • Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
981448305
Phone
+1 646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
  1. 4 Exercise or conversion Director acquired 75,000 shares (option exercise)
  2. 4 Gift CFO & COO gave 7,000 shares (gift)
  3. 4 Planned sale PRESIDENT & CEO sold 62,000 shares at $9.17 ($568,540)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4/A Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 7,814 shares (to pay taxes)
  7. 4 Grant or award Director acquired 555,555 shares (grant or award)
  8. 4 Planned sale CFO & COO sold 56,000 shares at $10.22 ($572,320)
  9. 4 Planned sale CHIEF DEV. OFFICER sold 27,661 shares at $9.36 ($258,907)
  10. 4 Planned sale PRESIDENT & CEO sold 62,000 shares at $7.41 ($459,420)
  11. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 2,952 shares (to pay taxes)
  12. 4 Shares withheld for taxes GENERAL COUNSEL AND SECRETARY gave up 5,949 shares (to pay taxes)
  13. 4 Shares withheld for taxes CHIEF DEV. OFFICER gave up 11,750 shares (to pay taxes)
  14. 4 Shares withheld for taxes CFO & COO gave up 31,726 shares (to pay taxes)
  15. 4 Shares withheld for taxes PRESIDENT & CEO gave up 33,048 shares (to pay taxes)
  16. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 13,951 shares (to pay taxes)
  17. 4 Shares withheld for taxes GENERAL COUNSEL AND SECRETARY gave up 27,206 shares (to pay taxes)
  18. 4 Shares withheld for taxes CHIEF DEV. OFFICER gave up 35,250 shares (to pay taxes)
  19. 4 Shares withheld for taxes CFO & COO gave up 163,916 shares (to pay taxes)
  20. 4 Shares withheld for taxes PRESIDENT & CEO gave up 163,916 shares (to pay taxes)

Page 2 of 13 · 260 filings